Texas Medical Center selects Deep 6 AI for accelerator

Texas Medical Center Innovation
Deep 6 AI Blog

Deep 6 AI Blog

Get insights about clinical trials, patient identification, health IT, data science, machine learning, and more.

Texas Medical Center selects Deep 6 AI for accelerator

Deep 6 AI is one of 23 digital health startups participating in the Texas Medical Center Accelerator (TMCx). The Texas Medical Center is the world’s largest medical center with 58 member institutions and a central research institute that provides a campus-wide R&D network, a central IRB for conducting multi-site trials, and 10 million annual patient encounters. The TMCx program, led by the TMC Innovation Institute, provides the tools and action plans necessary to move products and companies forward, regardless of stage of development, and lowers the barriers of access to hospital stakeholders and key opinion leaders across TMC. Participating startups, which were selected from more than 200 applications across 13 countries, get access to thought leaders and experts in every facet of running a health-related business – clinical trials, FDA regulations, HIPAA/HITECH compliance, hospital procurement, commercial pilots, intellectual property, licensing, fundraising, marketing, and more – without membership fees or equity sharing.

Joining Deep 6 AI in this sixth cohort are the following digital health companies: fellow Cedars-Sinai Accelerator powered by Techstars alum Well Health, Abaka HealthAgathos, b.well, DermaSensor, Etyon, Evidence Care, Gain Life, KlikkitLuminare, NarrativeDx, ORIntel, Particle Health, Patients We Share, RevealixScalaMed, SenceTech, Softcare StudiosStrados Labs, Sunrise HealthTrayt, and Trusted Health.

The four-month program will culminate in TMCx Demo Day on June 7, 2018.

Read more in MedCity News and TMC Xchange.


Share this post

Share on linkedin
Share on facebook
Share on twitter
Share on print
Share on email